Q3 2024 Earnings Estimate for Krystal Biotech, Inc. (NASDAQ:KRYS) Issued By William Blair
Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) – Analysts at William Blair increased their Q3 2024 EPS estimates for Krystal Biotech in a research note issued to investors on Tuesday, February 27th. William Blair analyst T. Lugo now expects that the company will post earnings of $0.41 per share for the quarter, up from their […]
More Stories
Rory McIlroy Wins Back-to-Back Masters Titles to Join Jack Nicklaus, Nick Faldo, and Tiger Woods
By The Associated Press AUGUSTA, Ga.—Rory McIlroy joined more elite company Sunday at the Masters when he pulled away with...
At Least 30 Dead in Stampede at Haiti’s Historic Laferriere Citadel
By Reuters At least 30 people were killed on Saturday in a stampede in the northern countryside of Haiti, authorities...
Oil Prices Rise After US Announces Blockade on Iranian Ports
By Naveen Athrappully Brent crude oil futures prices surged late Sunday following the United States threatening to block Iranian ports...
Eric Swalwell Ends Bid for California Governor Amid Sexual Misconduct Allegations
By Joseph Lord Rep. Eric Swalwell (D-Calif.) suspended his bid for California governor on Sunday after reports emerged accusing the...
Judge Orders Month-Long Pause on Process for Alberta Separation Referendum Petition
By Olivia Gomm An Alberta judge has granted a one-month stay on the validation process of a petition to trigger...
US to Blockade Strait of Hormuz After US–Iran Talks End Without Deal, Trump Says
By Jacki Thrapp The U.S. Navy will begin blockading the Strait of Hormuz after peace talks with Iran ended without...